Leyden Labs Gets €30 Million for Its Virus-Blocking Spray
Dutch biotech company Leyden Labs just secured a massive €30 million investment. They’re developing a nasal spray designed to block viruses like the flu at the source, offering immediate protection for everyone, including the most vulnerable. This could change how we handle seasonal sickness and future pandemics…